Access Group Thought Leadership

Hormonal IUD Access Group members pose for a group photo at FHI 360 - DC Office. Photo Credit: Natt Pladsri/FHI 360 In October 2024, the...

What is the Hormonal IUD Catalytic Opportunity Fund? The Catalytic Opportunity Fund (COF) is a rapid funding mechanism to support ...

Formed as a partnership between Population Council - the developers of the first hormonal IUD - and Schering (later acquired by Bayer AG)...

Compiled by the Clinton Health Access Initiative, two stories about hormonal IUD introduction - one in Zambia and one in Rwanda - capture...

The hormonal IUD digital training was originally developed by Population Services International and the Society for Family Health in...

This blog was originally posted by Catalyst Global here Written By: Danielle Harris, Deputy Director of Product Introduction, Catalyst...

From November 14-17, global leaders will convene for the International Conference on Family Planning. Check out these presentations and...

The High Impact Practices ( HIPs ) for Family Planning recently released a new Strategic Planning Guide, Contraceptive Method...

Guest Contributor | Kelly Dannucci, Sr. Manager, Global Access - Medicines360/Impact RH360 Harmonizing pharmaceutical product labeling...

This post has been adapted from another blog titled ‘Updated Couple Years of Protection: Literature Review and Guidance’. Original text...

This post originally appeared on the Research for Scalable Solutions blog. View original post here . In Nov 2020, global stakeholders...

This post originally appeared on the FP2030 website. View original post here . To read the article in French, please click here . To read...

Cet article a été initialement publié sur le site FP2030. Voyez le message original ici . Pour lire l'article en anglais, cliquez ici ....

Este anuncio fue publicado originalmente en el sitio web de FP2030. Para ver el anuncio original favor dar click aquí . El dispositivo...

This post originally appeared on the Contraceptive Technology Innovation Exchange website. View original post here . The Food and Drug...

Written by: Katie Williams, F ellow, FHI 360 & UNC Gillings School of Global Health Recently, the World Health Organization (WHO) issued...

This post originally appeared on the USAID website. View original post here . In April 2021, the levonorgestrel-releasing intrauterine...

Guest Contributors | Chastain Mann, EECO Project Director, WCG Cares & Ashley Jackson, EECO Project Deputy Director, PSI This post...

Written by: Katie Williams, Fellow, FHI 360 & UNC Gillings School of Global Health A new module featuring the levonorgestrel...

Written by: Catherine Todd, Associate Director, Reproductive, Maternal, Newborn & Child Health Originally published on FHI 360’s R&E...